Peritoneal Dialysis Versus Haemodialysis

Not Applicable

Completed

• Conditions: Hemodialysis

• Registration Number: NCT00752583
• Lead Sponsor: University Hospital, Ghent

Brief Summary

Study in order to quantify toxin removal during dialysis

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2008-09-12
• Study First Submitted QC: 2008-09-12
• Study First Posted: 2008-09-15
• Study Start: 2008-11-07
• Primary Completion: 2015-11-30
• Study Completion: 2015-12-31
• Status Verified: 2022-12
• Last Update Submitted: 2022-12-14
• Last Update Posted: 2022-12-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 25

Inclusion Criteria

• Substudy 1: includes new starting dialysis patients on peritoneal dialysis PD or haemodialysis HD
• Substudy 2: stabile haemodialysis patients and peritoneal dialysis patients. Patients will be matched for gender, time on dialysis, diabetes, renal function at the start of dialysis.
• Substudy 3: patients on CAPD (continuous ambulant PD) or CCPD (continuous cyclic PD).

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Registration of toxin removal efficiency	After 1 week and after 1, 3, 6, 9, 12, 18 and 24 months

Trial Locations

Locations (1)

University Hospital Ghent; 🇧🇪 Ghent, Belgium